Abbott Labs Vs. Pfizer: Which Discounted Healthcare Titan Screens as the Bigger Value Trap?24/7 Wall Street • 07/13/26
Unlocking Q2 Potential of Abbott (ABT): Exploring Wall Street Estimates for Key MetricsZacks Investment Research • 07/13/26
Abbott Labs Vs. Danaher: Abbott's Everyday Products Beat Danaher's Slumping Biotech Equipment24/7 Wall Street • 07/10/26
Brokers Suggest Investing in Abbott (ABT): Read This Before Placing a BetZacks Investment Research • 07/09/26
Eli Lilly and Novo Nordisk Are Fine -- but These 2 Stocks Could Be an Even Better Way to Invest in the GLP-1 BoomThe Motley Fool • 07/07/26
Abbott Laboratories Q2 Earnings Preview: A Contrarian Buy Opportunity Worth ConsideringSeeking Alpha • 07/03/26
5 Underperforming Dividend Kings Offer Big Passive Income and Huge Total Return Potential24/7 Wall Street • 07/02/26
Here Are Wednesday's Best Wall Street Analyst Research Calls: Abbott Laboratories, Circle Internet, Dow, Kratos Defense, Lockheed Martin, Salesforce, ServiceNow,SpaceX, and More24/7 Wall Street • 07/01/26
Abbott (ABT) Stock Falls Amid Market Uptick: What Investors Need to KnowZacks Investment Research • 06/29/26
Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.Market Watch • 06/29/26
How Abbott's Largest Segment Is Preparing for the Next Growth PhaseZacks Investment Research • 06/29/26
In a Volatile Market, This Dividend Growth Stock Is Worth Every Penny of $1,000The Motley Fool • 06/28/26
Abbott vs. DexCom: Which CGM Stock Is the Better Option Right Now?Zacks Investment Research • 06/26/26
Buy, Hold, or Sell: Tech Compression Dragged Abbott Labs Under $91, but 1 Massive Diabetes Catalyst Makes It a Screaming Buy24/7 Wall Street • 06/25/26